Physician profile
Janalee Webb
NPI 1760144067
$832.35
in general payments reported to CMS, 2019-2025
12 companies · $228 in 2025
The $228 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $337 · 2022: $153 · 2023: $77.43 · 2024: $36.93 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $342.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $351.96 | 2021-2024 | Ozempic |
| Exeltis, USA INC. | $159.49 | 2025 | Slynd, Twirla |
| Ironshore Pharmaceuticals INC. | $77.63 | 2022 | |
| Corium, LLC | $42.09 | 2023 | Azstarys |
| Lilly USA, LLC | $41.53 | 2024-2025 | Zepbound, Mounjaro |
| Pfizer INC. | $35.34 | 2023 | |
| Becton, Dickinson and Company | $29.63 | 2025 | |
| Organon LLC | $27.53 | 2022 | |
| Merck Sharp & Dohme LLC | $19.72 | 2022 | |
| Exact Sciences Corporation | $18.97 | 2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $14.50 | 2022 | |
| Tris Pharma INC | $13.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janalee Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.